5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references137

          • Record: found
          • Abstract: found
          • Article: not found

          PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

          Somatic mutations have the potential to encode "non-self" immunogenic antigens. We hypothesized that tumors with a large number of somatic mutations due to mismatch-repair defects may be susceptible to immune checkpoint blockade.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

            The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed that colorectal cancers with mismatch repair deficiency were sensitive to immune checkpoint blockade with antibodies to programmed death receptor-1 (PD-1). We have now expanded this study to evaluate the efficacy of PD-1 blockade in patients with advanced mismatch repair-deficient cancers across 12 different tumor types. Objective radiographic responses were observed in 53% of patients, and complete responses were achieved in 21% of patients. Responses were durable, with median progression-free survival and overall survival still not reached. Functional analysis in a responding patient demonstrated rapid in vivo expansion of neoantigen-specific T cell clones that were reactive to mutant neopeptides found in the tumor. These data support the hypothesis that the large proportion of mutant neoantigens in mismatch repair-deficient cancers make them sensitive to immune checkpoint blockade, regardless of the cancers' tissue of origin.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.

              Regulatory T cells (Tregs) that express the transcription factor Foxp3 are critical for regulating intestinal inflammation. Candidate microbe approaches have identified bacterial species and strain-specific molecules that can affect intestinal immune responses, including species that modulate Treg responses. Because neither all humans nor mice harbor the same bacterial strains, we posited that more prevalent factors exist that regulate the number and function of colonic Tregs. We determined that short-chain fatty acids, gut microbiota-derived bacterial fermentation products, regulate the size and function of the colonic Treg pool and protect against colitis in a Ffar2-dependent manner in mice. Our study reveals that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                International Journal of Cancer
                Int. J. Cancer
                Wiley
                0020-7136
                1097-0215
                February 15 2021
                August 03 2020
                February 15 2021
                : 148
                : 4
                : 800-811
                Affiliations
                [1 ]Department of Applied Tumour Biology Institute of Pathology, University Hospital Heidelberg Heidelberg Germany
                [2 ]Cooperation Unit Applied Tumour Biology German Cancer Research Centre (DKFZ) Heidelberg Germany
                [3 ]Molecular Medicine Partnership Unit (MMPU) European Molecular Biology Laboratory (EMBL) Heidelberg Germany
                [4 ]Department of Surgery Helsinki University Central Hospital Helsinki Finland
                [5 ]Faculty of Medicine University of Helsinki Helsinki Finland
                [6 ]Surgical Oncology Johns Hopkins Hospital Baltimore Maryland USA
                [7 ]Department of Statistics and Epidemiology Institute for Medical Informatics, University of Leipzig Leipzig Germany
                [8 ]Translational and Clinical Research Institute, Faculty of Medical Sciences Newcastle University Newcastle UK
                [9 ]International Centre for Life Central Parkway, Newcastle upon Tyne UK
                [10 ]Medizinische Klinik und Poliklinik IV Campus Innenstadt, Klinikum der Universität München Munich Germany
                [11 ]Centre of Medical Genetics Munich Germany
                [12 ]Centre for Hereditary Tumors HELIOS Klinikum Wuppertal, University Witten‐Herdecke Wuppertal Germany
                [13 ]Department of Clinical Genetics Leiden University Medical Centre Leiden the Netherlands
                [14 ]Department of Clinical Genetics University of Groningen, University Medical Centre Groningen Groningen the Netherlands
                [15 ]Molecular Gastroenterology and Department of Gastroenterology Humanitas Clinical and Research Center Milan Italy
                [16 ]Department of Medicine and Surgery University of Parma Parma Italy
                [17 ]Department of Tumor Biology Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital Oslo Norway
                [18 ]Hereditary Cancer Program Institut Catala d'Oncologia‐IDIBELL, L'Hospitalet de Llobregat Barcelona Spain
                [19 ]Colorectal Medicine and Genetics The Royal Melbourne Hospital Melbourne Australia
                [20 ]University of Newcastle and the Hunter Medical Research Institute Callaghan Australia
                [21 ]Department of Internal Medicine I University Hospital Bonn Bonn Germany
                [22 ]National Centre for Hereditary Tumor Syndromes University Hospital Bonn Bonn Germany
                [23 ]Division of Clinical Epidemiology and Aging Research German Cancer Research Center (DKFZ) Heidelberg Germany
                [24 ]Division of Preventive Oncology German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg Germany
                [25 ]German Cancer Consortium (DKTK) German Cancer Research Center (DKFZ) Heidelberg Germany
                [26 ]Institute of Pathology University Hospital Leipzig Leipzig Germany
                [27 ]Institute of Medical Genetics, Division of Cancer and Genetics Cardiff University School of Medicine Cardiff UK
                [28 ]Department of Gastroenterology & Hepatology Leiden University Medical Centre Leiden The Netherlands
                [29 ]Department of Surgery Central Finland Central Hospital Jyväskylä Finland
                [30 ]Faculty of Sport and Health Sciences University of Jyväskylä Jyväskylä Finland
                Article
                10.1002/ijc.33224
                32683684
                4b744d16-4066-4a36-9272-56d062074901
                © 2021

                http://creativecommons.org/licenses/by-nc-nd/4.0/

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article